TP53 and breast neoplasm: Among these, SAA1 and SAA2 were also upregulated in human breast tumors with mutant TP53 compared to those with wild-type TP53. Previous studies have implicated SAA1, SAA2, and THBS4 in promoting tumor progression via the PI3K/AKT pathway.